The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Value of NMO-IgG determination at the time of presentation as CIS
Abstract
Background Despite the availability of diagnostic criteria, an overlap between neuromyelitis optica (NMO) and multiple sclerosis (MS) exists, particularly in the early stage of the disease. Objective To study the value of NMO-immunoglobulin G (IgG) determination in Caucasian patients with a first demyelinating episode who develop a relapsing form of optic neuritis or myelitis. Methods This study was based on a prospectively acquired cohort of patients regarded as having a clinically isolated syndrome (CIS) at the time of presentation. From this cohort, 2 different groups were selected: group 1 (NMO phenotype), consisting of a first attack involving the optic nerve or the spinal cord, and at least a second event affecting either topography, and group 2 (negative control group), consisting of a first attack involving the brainstem or the cerebral hemispheres and at least 1 relapse in any topography. Group 3 was composed of patients with NMO according to the 2006 revised diagnostic criteria. Serum NMO-IgG was determined by indirect immunofluorescence. Results A total of 3.1 of the group 1 patients were positive for NMO-IgG in comparison to 3.9% of group 2 and 44.5% of group 3, NMO. One of the positive patients in group 1 evolved to NMO. Conclusions NMO-IgG determination is crucial in detecting patients who will develop NMO; however, its value as a routine test in cases presenting with symptoms of the type seen in MS is low, and should only be performed in those patients in which…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Although the first attack of NMOSD can mimic CIS, routine testing for AQP4-IgG in CIS populations with a high incidence of MS and low incidence of NMOSD has a very low yield and is not recommended.
“Although the first attack of NMOSD can mimic CIS (e.g.acute unilateral optic neuritis or short-segment partial myelitis 61 ), routine testing for AQP4-IgG in CIS populations with a high incidence of MS and low incidence of NMOSD has a very low yield and is not recommended.62”
From Diagnosis of multiple sclerosis: progress and challenges (2017) · cites this paper as [62]
Citations
Cites
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria
Polman, C. H., Reingold, S. C., Banwell, B., Clanet, M., Cohen, J. A., Filippi, M., Fujihara, K., Havrdova, E., Hutchinson, M., Kappos, L., et al. (2011) · Annals of Neurology · doi:10.1002/ana.22366 · Cited by 9,802
Self-citationA serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis
Lennon, V. A., Wingerchuk, D. M., Kryzer, T. J., Pittock, S. J., Lucchinetti, C. F., Fujihara, K., Nakashima, I., & Weinshenker, B. G. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17551-x · Cited by 3,239
Revised diagnostic criteria for neuromyelitis optica
Wingerchuk, D. M., Lennon, V. A., Pittock, S. J., Lucchinetti, C. F., & Weinshenker, B. G. (2006) · Neurology · doi:10.1212/01.wnl.0000216139.44259.74 · Cited by 2,568
Differential diagnosis of suspected multiple sclerosis: a consensus approach
Miller, D., Weinshenker, B., Filippi, M., Banwell, B., Cohen, J., Freedman, M., Galetta, S., Hutchinson, M., Johnson, R., Kappos, L., et al. (2008) · Multiple Sclerosis Journal · doi:10.1177/1352458508096878 · Cited by 642
Self-citationEFNS guidelines on diagnosis and management of neuromyelitis optica
Sellner, J., Boggild, M., Clanet, M., Hintzen, R. Q., Illés, Z., Montalbán, X., Pasquier, R. D., Polman, C. H., Sørensen, P. S., & Hemmer, B. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03066.x · Cited by 460
Aquaporin-4 Antibodies in Neuromyelitis Optica and Longitudinally Extensive Transverse Myelitis
Waters, P. J., Jarius, S., Littleton, E. T., Leite, M. I., Jacob, S., Gray, B., Geraldes, R., Vale, T., Jacob, A., Palace, J. A., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.7.913 · Cited by 295
Neuromyelitis optica in France
Collongues, N., Marignier, R., Zéphir, H., Papeix, C., Blanc, F., Ritleng, C., Tchikviladzé, M., Outteryck, O., Vukusic, S., Fleury, M., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d31e35 · Cited by 213
Revised diagnostic criteria for neuromyelitis optica (NMO)
for the Spanish–Italian NMO study group, Saiz, A., Zuliani, L., Blanco, Y., Tavolato, B. F., Giometto, B., & Graus, F. (2007) · Journal of Neurology · doi:10.1007/s00415-007-0509-8 · Cited by 97
Self-citationNMO‐IgG: A Specific Biomarker for Neuromyelitis Optica
Weinshenker, B. G., Wingerchuk, D. M., Pittock, S. J., Lucchinetti, C. F., & Lennon, V. A. (2006) · Disease Markers · doi:10.1155/2006/586306 · Cited by 94
Neuromyelitis optica diagnosis in clinically isolated syndromes suggestive of multiple sclerosis
Rubiera, M., Río, J., Tintoré, M., Nos, C., Rovira, À., Téllez, N., & Montalbán, X. (2006) · Neurology · doi:10.1212/01.wnl.0000216233.56611.c2 · Cited by 26
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Diagnosis of multiple sclerosis: progress and challenges
Brownlee, W. J., Hardy, T. A., Fazekas, F., & Miller, D. H. (2017) · The Lancet · doi:10.1016/s0140-6736(16)30959-x · Cited by 701
Metadata
- Authors
- Costa, C., Arrambide, G., Tintore, M., Castilló, J., Sastre-Garriga, J., Tur, C., Río, J., Saiz, A., Vidal-Jordana, A., Auger, C., Nos, C., Rovira, A., Comabella, M., Horga, A., & Montalban, X.
- Affiliations
- Universitat Autònoma de Barcelona (ES)
- From the Unitat de Neuroimmunologia Clinica (UNiC), Centre d'Esclerosi Múltiple de Catalunya (CEM-Cat), Vall d'Hebron Institut de Recerca (VHIR) (C.C., G.A., M.T., J.C., J.S.-G., C.T., J.R., A.V.-J., C.N., M.C., A.H., X.M.), and Magnetic Resonance Unit (IDI), Department of Radiology (C.A., A.R.), Hospital Universitari Vall d'Hebron, Universitat Autònoma de Barcelona; and Service of Neurology (A.S.), Hospital Clinic, Universitat de Barcelona and Institut d' Investigació Biomèdica August Pi i Sunyer ...
- Venue
- Neurology
- Published
- 2012-05-15
- Volume
- 78
- Issue
- 20
- Pages
- 1608-1611
- ISSN
- 0028-3878 (ISSN-L)
- 1526-632X
- OpenAlex
- W2137131203
- Cited by
- 17
- References
- 10
- Citations by year
- 2024: 1 · 2022: 1 · 2018: 2 · 2017: 1 · 2016: 4 · 2015: 3 · 2014: 3 · 2013: 1 · 2012: 1
- FWCI
- 1.85
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neurology (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Keywords
- neuromyelitis optica, aquaporin-4 antibodies, clinically isolated syndrome, multiple sclerosis, serological diagnosis, optic neuritis, myelitis, demyelinating disease, diagnostic criteria, disease progression
- MeSH terms
- Adolescent, Adult, Demyelinating Diseases, Female, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Neuromyelitis Optica, Retrospective Studies, Time Factors, Cohort Studies, Oligoclonal Bands, White People, Aquaporin 4, Young Adult
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review